Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera-Reference-Cited by-同舟云学术

Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera

Published:2012-05-18 Issue:5 Volume:7 Page:e37207
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kraus Manfred,Wang Yuxun,Aleksandrowicz Dan,Bachman Eric,Szewczak Alexander A.,Walker Deborah,Xu Lin,Bouthillette Melaney,Childers Kaleen M.,Dolinski Brian,Haidle Andrew M.,Kopinja Johnny,Lee Linda,Lim Jongwon,Little Kevin D.,Ma Yanhong,Mathur Anjili,Mo Jan-Rung,O’Hare Erin,Otte Ryan D.,Taoka Brandon M.,Wang Wenxian,Yin Hong,Zabierek Anna A.,Zhang Weisheng,Zhao Shuxia,Zhu Joe,Young Jonathan R.,Marshall C. Gary

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Prevalence of polycythemia vera and essential thrombocythemia.;X Ma;Am J Hematol,2008

2. Polycythaemia vera and essential thrombocythaemia: current treatment strategies.;EI Penninga;Drugs,2006

3. Current management of the myeloproliferative disorders: a case-based review.;L Rice;Arch Pathol Lab Med,2006

4. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.;RA Mesa;Cancer,2007

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.;EJ Baxter;Lancet,2005

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycythemia vera: the current status of preclinical models and therapeutic targets;Expert Opinion on Therapeutic Targets;2020-05-18

2. Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer;Oncotarget;2017-08-02

3. In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs;ILAR Journal;2016-12

4. The Chemopreventive Phytochemical Moringin Isolated from Moringa oleifera Seeds Inhibits JAK/STAT Signaling;PLOS ONE;2016-06-15

5. Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening;Journal of Chemical Information and Modeling;2015-12-31